Literature DB >> 27902989

Plasma Levels of Leptin and Adiponectin in Fragile X Syndrome.

Małgorzata Zofia Lisik1, Ewa Gutmajster, Aleksander L Sieroń.   

Abstract

Fragile X syndrome (FXS) is the most common form of familial mental retardation and one of the leading known causes of autism. The mutation responsible for FXS is a large expansion of the CGG repeats in the promoter region of the FMR1 gene, resulting in the transcriptional silencing of the gene. Leptin may be considered a cytokine-like hormone with pleiotropic actions since it may be involved in the regulation of neuroendocrine functions and the immune system response, in addition to playing a role in development. Leptin and adiponectin may act in parallel as opposing metabolic counterparts. The involvement of leptin and adiponectin in the pathophysiology of FXS was hypothesized.
MATERIAL AND METHODS: Twenty-three male patients affected by FXS (full mutation in the FMR1 gene) and 24 controls were included in the study. Plasma leptin and adiponectin levels were measured by the ELISA method using commercially available kits.
RESULTS: Adiponectin levels in FXS patients were significantly lower than those found in controls (p < 0.04). Leptin levels in FXS patients were significantly higher than those found in controls (p = 0.03).
CONCLUSION: Adipokines may be involved in the psychiatric features observed in FXS patients. Further investigations are necessary to evaluate the role of adiponectin and leptin in FXS.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27902989     DOI: 10.1159/000452336

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  7 in total

1.  Serum adiponectin levels are reduced in autism spectrum disorder and association with severity of symptoms.

Authors:  Lijuan Quan; Yue Zhao; Jinping Yi; Xiao-Dong Shi; Yingjun Zhong; Lingling Liu
Journal:  Metab Brain Dis       Date:  2021-01-20       Impact factor: 3.584

2.  Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model.

Authors:  Cara J Westmark; Mikolaj J Filon; Patricia Maina; Lauren I Steinberg; Chrysanthy Ikonomidou; Pamela R Westmark
Journal:  Cells       Date:  2022-04-15       Impact factor: 7.666

3.  Cord and Early Childhood Plasma Adiponectin Levels and Autism Risk: A Prospective Birth Cohort Study.

Authors:  Ramkripa Raghavan; M Daniele Fallin; Xiumei Hong; Guoying Wang; Yuelong Ji; Elizabeth A Stuart; David Paige; Xiaobin Wang
Journal:  J Autism Dev Disord       Date:  2019-01

4.  Maternal Midpregnancy Leptin and Adiponectin Levels as Predictors of Autism Spectrum Disorders: A Prenatal Cohort Study.

Authors:  Kyoung Eun Joung; Sheryl L Rifas-Shiman; Emily Oken; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

Review 5.  Cardiovascular Implications in Idiopathic and Syndromic Obesity in Childhood: An Update.

Authors:  Maurizio Delvecchio; Carmela Pastore; Federica Valente; Paola Giordano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-09       Impact factor: 5.555

6.  Leptin down-regulates KCC2 activity and controls chloride homeostasis in the neonatal rat hippocampus.

Authors:  Camille Dumon; Yasmine Belaidouni; Diabe Diabira; Suzanne M Appleyard; Gary A Wayman; Jean-Luc Gaiarsa
Journal:  Mol Brain       Date:  2020-11-12       Impact factor: 4.041

7.  The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice.

Authors:  Camille Dumon; Diabe Diabira; Ilona Chudotvorova; Francesca Bader; Semra Sahin; Jinwei Zhang; Christophe Porcher; Gary Wayman; Igor Medina; Jean-Luc Gaiarsa
Journal:  Elife       Date:  2018-08-14       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.